HELIXMITH

Live / Registered — Registered (as of 02 Nov 2021)

What this means for you

Registered since 02 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number: 79300661
Registration number: 6541689
Mark type: Design + words
Filed: 11 Nov 2020
Published for opposition: 17 Aug 2021
Registered: 02 Nov 2021
Attorney of record: Daniel P. Mullarkey

Goods and services

Class 005 — Pharmaceuticals: Pharmaceutical preparations for health care for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Crude medicines for treating neurological diseases, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related disease; Pharmaceutical preparations extracted from crude medicine for treating neurological diseases, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; reagents for use in veterinary genetic testing; dietary supplement drinks; dietary supplements; chemical preparations for pharmaceutical purposes for treating chemical imbalances; Gene therapy preparations for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, or cancer; Drugs for medical purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; chemical preparations for use in dna analysis for medical diagnostic purposes; Biological preparations for medical for veterinary purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, or cancer; reagents for use in medical genetic testing; Pharmaceutical drugs for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Medicines for human purposes for treating neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; Pharmaceutical preparations for diagnosis for cancer or renal diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; Ethical medicinal preparations for the treatment of neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; nutraceutical preparations for therapeutic or medical purposes; Therapeutic drugs and agents for the treatment of neurological diseases, muscular diseases, ischemic diseases, renal diseases, cancer, inflammatory diseases, allergy, respiratory diseases, urologic diseases, cardiovascular diseases, menopause symptoms, or immune system related diseases; health functional food being dietetic foods mainly based on Korean herbal medicines
Class 035 — Advertising and business services: Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; wholesale store services featuring gene therapy preparations; retail store services featuring gene therapy preparations; retail services by direct solicitation by sales agents in the field of gene therapy preparations; retail store services featuring chemical preparations for use in DNA analysis for medical purposes; retail store services featuring biological preparations for medical or veterinary purposes; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; wholesale store services featuring therapeutic drugs and agents; retail store services featuring therapeutic drugs and agents
Class 042 — Scientific and technological services: Research and development of vaccines and medicines; biotechnological research; development of new products for others in the field of biotechnology; scientific research in the fields of biomedicine; Scientific research and chemical testing services in the fields of bacteriology and virology; drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical products development; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; research of pharmaceuticals; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services

Owner

Prosecution history

16 May 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
25 Apr 2022 — FINAL DISPOSITION NOTICE SENT TO IB
25 Apr 2022 — FINAL DISPOSITION PROCESSED
02 Feb 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
17 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17 Aug 2021 — PUBLISHED FOR OPPOSITION
15 Aug 2021 — NOTIFICATION PROCESSED BY IB
28 Jul 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
28 Jul 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
28 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14 Jul 2021 — ASSIGNED TO LIE
14 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
13 Jul 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
13 Jul 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy